The metastasis gene osteopontin: a candidate target for cancer therapy.
about
Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcomaMatricellular proteins: a sticky affair with cancersOverexpression of miR-30b in the developing mouse mammary gland causes a lactation defect and delays involutionHigher Matrix Stiffness Upregulates Osteopontin Expression in Hepatocellular Carcinoma Cells Mediated by Integrin β1/GSK3β/β-Catenin Signaling PathwayPathway analysis of primary central nervous system lymphoma.Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process.Identification of osteopontin-dependent signaling pathways in a mouse model of human breast cancer.Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients.Cancer and the tumor microenvironment: a review of an essential relationship.Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells.Elevation of osteopontin levels in brain tumor cells reduces burden and promotes survival through the inhibition of cell dispersalVDA, a method of choosing a better algorithm with fewer validationsOsteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression.Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancerPre- and post-translational regulation of osteopontin in cancer.CD10 and osteopontin expression in dentigerous cyst and ameloblastoma.Functional characterization of OPN in human laryngeal squamous cell carcinoma and its xenograft model in nude miceMyeloma cell-derived Runx2 promotes myeloma progression in bone.Association of OPN overexpression with tumor stage, differentiation, metastasis and tumor progression in human laryngeal squamous cell carcinoma.Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts.Growth factor signaling induces metastasis genes in transformed cells: molecular connection between Akt kinase and osteopontin in breast cancerElevated plasma osteopontin associated with gastric cancer development, invasion and survival.Intracellular signal transduction and modification of the tumor microenvironment induced by RET/PTCs in papillary thyroid carcinoma.Osteopontin regulates ubiquitin-dependent degradation of Stat1 in murine mammary epithelial tumor cells.Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner.Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension.Identification of therapeutic targets for glioblastoma by network analysis.Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma.The Effect of Polymorphisms in SPP1 on Risk of Fracture: A Case-Control Study.Osteopontin expression in papillary thyroid carcinoma and its relationship with the BRAF mutation and tumor characteristicsMatricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localizationThe epigenetic landscape of oral squamous cell carcinomaOPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome.Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer.Structural requirements for bone sialoprotein binding and modulation of matrix metalloproteinase-2.Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma.Biomolecular markers in cancer of the tongue.Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontin.OPN and αvβ3 expression are predictors of disease severity and worse prognosis in hepatocellular carcinoma.NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.
P2860
Q21260421-4CD15E3F-9F3A-4898-929B-0CC5374DCBDCQ21296660-193790FF-9941-4C2F-9C37-1EA3F6E4F59DQ27317285-7A60BE6E-501E-44F3-9F3B-4BAC89B0A70BQ28547308-33798041-57A5-4D2A-A689-3260953FBBFFQ30481424-28724007-FC85-48C0-83CA-52D8900DBD90Q33281964-5E9DE3F1-D230-4DE8-817D-6A3D068C3A47Q33477106-BCB373A2-3892-4E80-9EBC-EC0A79BD2337Q33551004-41D00CE1-55F4-480E-8C8D-1DC25E72FCE0Q33806357-9081964C-5627-49E3-A438-63565A143BC6Q34025851-3F6FD18E-7B2F-4122-BE5D-1E44299A8F55Q34026529-F152EF5C-1E29-403B-835D-5C25A9F188D3Q34064348-E13FDDEF-D9D4-4495-B6AD-63D3F765E32BQ34451146-74194E38-B46B-400E-B1BC-059C43B3D103Q34655823-F86D4847-2C2E-4795-876D-18B1677BA7B2Q34939938-1F382525-DC33-4F30-AF97-7F4800A2495FQ35054580-CA0221E9-865C-4D3F-AA66-4497A8211A49Q35173409-F1C1FC4C-4934-4097-8E89-9AE8703B9C64Q35692401-31EF3DCB-4E2E-4B1F-A62E-6E5B298D6295Q35870683-5250D838-0001-4FBF-ABFF-0F00FAC613EBQ35916025-1175065C-B133-453F-BBF4-089A0AF2EDC9Q35920825-EFD8E08F-1618-44A9-BB8B-7DFEE098127AQ35953813-41905FC8-81A6-44CD-AD74-CC8FD0BDF72CQ35977327-85F8A2D4-CBD0-46E0-9DAF-1A09EFF0D113Q36012548-0706BB9F-9E71-4656-BA86-209586EBC080Q36093343-66E7075D-5EEE-41ED-B436-0DF7AA8428D5Q36185483-414395E6-B047-47E8-BA8B-215F73CF0144Q36271573-6F1D53EE-3340-437E-8762-235CADBB0760Q36355935-5B325E4B-8A4F-4CAD-85A8-FC1ED3E73B56Q36377357-A3BD8C93-5C32-4268-A0DF-35966B211B5BQ36514930-8ACBA443-B8F5-4758-8DF8-366876AB0B37Q36578825-6C22ECB7-F664-4CF4-8597-A5A93269678DQ36594150-BD7E4AC8-EBD9-4843-82FD-E1DF54E3824BQ36610720-C3BF2429-EBC4-417E-A0C1-AA98E2B5D1F9Q36615218-083D3F64-77AC-4487-A242-DBBE9B6506AFQ36952540-CA1B6B33-1120-4773-9298-E0FC5E3FD24AQ37234183-9F71FDA8-2239-44B1-A5E8-C4C090AFB8E6Q37310520-3CD30F5E-A669-4EFB-AADF-482B97E5134EQ37344830-26FF47F1-FB66-43DB-AC6F-1D3CF0BD35B6Q37549325-AB34826C-B248-497A-A842-A60CB29AEF68Q37707767-DA4DBFE1-4044-4EBA-AF98-ACDC9853A3B8
P2860
The metastasis gene osteopontin: a candidate target for cancer therapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The metastasis gene osteopontin: a candidate target for cancer therapy.
@ast
The metastasis gene osteopontin: a candidate target for cancer therapy.
@en
The metastasis gene osteopontin: a candidate target for cancer therapy.
@nl
type
label
The metastasis gene osteopontin: a candidate target for cancer therapy.
@ast
The metastasis gene osteopontin: a candidate target for cancer therapy.
@en
The metastasis gene osteopontin: a candidate target for cancer therapy.
@nl
prefLabel
The metastasis gene osteopontin: a candidate target for cancer therapy.
@ast
The metastasis gene osteopontin: a candidate target for cancer therapy.
@en
The metastasis gene osteopontin: a candidate target for cancer therapy.
@nl
P1476
The metastasis gene osteopontin: a candidate target for cancer therapy.
@en
P2093
P356
10.1016/S0304-419X(01)00037-3
P407
P577
2001-12-01T00:00:00Z